References
- Chong ZZ, Li F, Maiese K. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Brain Res Rev 2005;49:1–21.
- Smith MA, Nunomura A, Lee HG, Zhu X, Moreira PI, Avila J, Perry G. Chronological primacy of oxidative stress in Alzheimer disease. Neurobiol Aging 2005;26:579–580.
- Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide- associated free radical oxidative stress. Free Radic Biol Med 2002;32:1050–1060.
- Liu Q, Smith MA, Avila J, DeBernardis J, Kansal M, Takeda A, et al. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. Free Radic Biol Med 2005;38:746–754.
- Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K, et al. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 2005;12:19–24.
- Block ML. NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci 2008;9:S8.
- Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 2002;32:797–803.
- Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005;38:1543–1552.
- Fisher AB. Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A(2) activities. Antioxid Redox Signal 2011;15:831–844.
- Power JH, Asad S, Chataway TK, Chegini F, Manavis J, Temlett JA, et al. Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology. Acta Neuropathol 2008;115:611–622.
- Power JH, Shannon JM, Blumbergs PC, Gai WP. Nonselenium glutathione peroxidase in human brain: elevated levels in Parkinson's disease and dementia with lewy bodies. Am J Pathol 2002;161:885–894.
- Krapfenbauer K, Yoo BC, Fountoulakis M, Mitrova E, Lubec G. Expression patterns of antioxidant proteins in brains of patients with sporadic Creutzfeldt-Jacob disease. Electrophoresis 2002;23:2541–2547.
- Cumming RC, Dargusch R, Fischer WH, Schubert D. Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells. J Biol Chem 2007;282:30523–30534.
- Lee YM, Park SH, Shin DI, Hwang JY, Park B, Park YJ, et al. Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. J Biol Chem 2008;283:9986–9998.
- De Simoni S, Goemaere J, Knoops B. Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+. Neurosci Lett 2008;433: 219–224.
- Li G, Ma R, Huang C, Tang Q, Fu Q, Liu H, et al. Protective effect of erythropoietin on beta-amyloid-induced PC12 cell death through antioxidant mechanisms. Neurosci Lett 2008; 442:143–147.
- Pak JH, Choi WH, Lee HM, Joo WD, Kim JH, Kim YT, et al. Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells. Cancer Invest 2011;29:21–28.
- Manevich Y, Sweitzer T, Pak JH, Feinstein SI, Muzykantov V, Fisher AB. 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc Natl Acad Sci U S A 2002;99:11599–11604.
- Wang X, Chen Q, Xing D. Focal adhesion kinase activates NF-kappaB via the ERK1/2 and p38MAPK Pathways in amyloid-beta25-35-induced apoptosis in PC12 cells. J Alzheimers Dis 2012;32:77–94.
- Evangelisti E, Wright D, Zampagni M, Cascella R, Fiorillo C, Bagnoli S, et al. Lipid rafts mediate amyloid-induced calcium dyshomeostasis and oxidative stress in Alzheimer's disease. Curr Alzheimer Res 2013;10:143–153.
- Jang JH, Aruoma OI, Jen LS, Chung HY, Surh YJ. Ergothioneine rescues PC12 cells from beta-amyloid- induced apoptotic death. Free Radic Biol Med 2004;36: 288–299.
- Pereira C, Santos MS, Oliveira C. Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells. Neuroreport 1998;9:1749–1755.
- Venturini G, Colasanti M, Persichini T, Fioravanti E, Ascenzi P, Palomba L, et al. Beta-amyloid inhibits NOS activity by subtracting NADPH availability. FASEB J 2002; 16:1970–1972.
- Markesbery WR, Lovell MA. DNA oxidation in Alzheimer's disease. Antioxid Redox Signal 2006;8:2039–2045.
- Spuch C, Ortolano S, Navarro C. New insights in the amyloid-Beta interaction with mitochondria. J Aging Res 2012;2012: 324968.
- Chen JX, Yan SS. Role of mitochondrial amyloid-beta in Alzheimer's disease. J Alzheimers Dis 2010;20:569–578.
- Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; 9:231–241.
- Morais Cardoso S, Swerdlow RH, Oliveira CR. Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria. Brain Res 2002;931: 117–125.
- Mairuae N, Hall Ii EC, Cheepsunthorn P, Lee SY, Connor JR. The H63D HFE gene variant promotes activation of the intrinsic apoptotic pathway via mitochondria dysfunction following beta-amyloid peptide exposure. J Neurosci Res 2010;88:3079–3089.
- Kim HS, Manevich Y, Feinstein SI, Pak JH, Ho YS, Fisher AB. Induction of 1-cys peroxiredoxin expression by oxidative stress in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2003;285:L363–369.
- Gallagher BM, Phelan SA. Investigating transcriptional regulation of Prdx6 in mouse liver cells. Free Radic Biol Med 2007;42:1270–1277.
- Tchah H, Kim MJ, Kim TI, Choi HJ, Kim JY, Kim MJ, Pak JH. Regulation of 1-cys peroxiredoxin expression in the process of stromal wound healing after photorefractive keratectomy. Invest Ophthalmol Vis Sci 2005;46:2396–2403.
- Wang Y, Feinstein SI, Fisher AB. Peroxiredoxin 6 as an antioxidant enzyme: protection of lung alveolar epithelial type II cells from H2O2-induced oxidative stress. J Cell Biochem 2008;104:1274–1285.
- Pak JH, Manevich Y, Kim HS, Feinstein SI, Fisher AB. An antisense oligonucleotide to 1-cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells. J Biol Chem 2002;277:49927–49934.
- Wang Y, Feinstein SI, Manevich Y, Ho YS, Fisher AB. Peroxiredoxin 6 gene-targeted mice show increased lung injury with paraquat-induced oxidative stress. Antioxid Redox Signal 2006;8:229–237.
- Eismann T, Huber N, Shin T, Kuboki S, Galloway E, Wyder M, et al. Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am J Physiol Gastrointest Liver Physiol 2009; 296:G266–274.
- Yun HM, Jin P, Han JY, Lee MS, Han SB, Oh KW, et al. Acceleration of the development of Alzheimer's disease in amyloid beta-infused peroxiredoxin 6 overexpression transgenic mice. Mol Neurobiol 2013. [Epub ahead of print]
- Sun GY, Xu J, Jensen MD, Yu S, Wood WG, Gonzalez FA, et al. Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists. Mol Neurobiol 2005;31:27–41.